4//SEC Filing
SVLSF VI, LLC 4
Accession 0000899243-18-017965
CIK 0001681087other
Filed
Jun 24, 8:00 PM ET
Accepted
Jun 25, 6:16 PM ET
Size
27.6 KB
Accession
0000899243-18-017965
Insider Transaction Report
Form 4
AVROBIO, Inc.AVRO
SVLSF VI, LLC
10% Owner
Transactions
- Conversion
Common Stock
2018-06-25+2,207,843→ 2,207,843 total(indirect: See Footnote) - Conversion
Common Stock
2018-06-25+75,591→ 75,591 total(indirect: See Footnote) - Conversion
Common Stock
2018-06-25+14,982→ 90,573 total(indirect: See Footnote) - Conversion
Series A Preferred Stock
2018-06-25−9,122,809→ 0 total(indirect: See footnote)→ Common Stock (2,207,843 underlying) - Conversion
Series B Preferred Stock
2018-06-25−1,808,211→ 0 total(indirect: See footnote)→ Common Stock (437,611 underlying) - Conversion
Series B Preferred Stock
2018-06-25−61,908→ 0 total(indirect: See footnote)→ Common Stock (14,982 underlying) - Conversion
Common Stock
2018-06-25+437,611→ 2,645,454 total(indirect: See Footnote) - Conversion
Series A Preferred Stock
2018-06-25−312,341→ 0 total(indirect: See footnote)→ Common Stock (75,591 underlying)
SV Life Sciences Fund VI, L.P.
10% Owner
Transactions
- Conversion
Series B Preferred Stock
2018-06-25−61,908→ 0 total(indirect: See footnote)→ Common Stock (14,982 underlying) - Conversion
Common Stock
2018-06-25+75,591→ 75,591 total(indirect: See Footnote) - Conversion
Series B Preferred Stock
2018-06-25−1,808,211→ 0 total(indirect: See footnote)→ Common Stock (437,611 underlying) - Conversion
Common Stock
2018-06-25+2,207,843→ 2,207,843 total(indirect: See Footnote) - Conversion
Common Stock
2018-06-25+437,611→ 2,645,454 total(indirect: See Footnote) - Conversion
Common Stock
2018-06-25+14,982→ 90,573 total(indirect: See Footnote) - Conversion
Series A Preferred Stock
2018-06-25−312,341→ 0 total(indirect: See footnote)→ Common Stock (75,591 underlying) - Conversion
Series A Preferred Stock
2018-06-25−9,122,809→ 0 total(indirect: See footnote)→ Common Stock (2,207,843 underlying)
Transactions
- Conversion
Common Stock
2018-06-25+75,591→ 75,591 total(indirect: See Footnote) - Conversion
Common Stock
2018-06-25+14,982→ 90,573 total(indirect: See Footnote) - Conversion
Series A Preferred Stock
2018-06-25−312,341→ 0 total(indirect: See footnote)→ Common Stock (75,591 underlying) - Conversion
Series B Preferred Stock
2018-06-25−61,908→ 0 total(indirect: See footnote)→ Common Stock (14,982 underlying) - Conversion
Common Stock
2018-06-25+2,207,843→ 2,207,843 total(indirect: See Footnote) - Conversion
Common Stock
2018-06-25+437,611→ 2,645,454 total(indirect: See Footnote) - Conversion
Series A Preferred Stock
2018-06-25−9,122,809→ 0 total(indirect: See footnote)→ Common Stock (2,207,843 underlying) - Conversion
Series B Preferred Stock
2018-06-25−1,808,211→ 0 total(indirect: See footnote)→ Common Stock (437,611 underlying)
SV Life Sciences Fund VI (GP), L.P.
10% Owner
Transactions
- Conversion
Common Stock
2018-06-25+437,611→ 2,645,454 total(indirect: See Footnote) - Conversion
Common Stock
2018-06-25+14,982→ 90,573 total(indirect: See Footnote) - Conversion
Series A Preferred Stock
2018-06-25−312,341→ 0 total(indirect: See footnote)→ Common Stock (75,591 underlying) - Conversion
Common Stock
2018-06-25+75,591→ 75,591 total(indirect: See Footnote) - Conversion
Series B Preferred Stock
2018-06-25−1,808,211→ 0 total(indirect: See footnote)→ Common Stock (437,611 underlying) - Conversion
Common Stock
2018-06-25+2,207,843→ 2,207,843 total(indirect: See Footnote) - Conversion
Series A Preferred Stock
2018-06-25−9,122,809→ 0 total(indirect: See footnote)→ Common Stock (2,207,843 underlying) - Conversion
Series B Preferred Stock
2018-06-25−61,908→ 0 total(indirect: See footnote)→ Common Stock (14,982 underlying)
Footnotes (7)
- [F1]Represents the total number of shares of Common Stock received by SV Life Sciences Fund VI, L.P. ("SV Life LP") upon the conversion of the Issuer's Series A Preferred Stock in connection with the closing of the Issuer's initial public offering.
- [F2]The shares are held directly by SV Life LP. SV Health Investors, LLC is the Manager of SV Life LP. SV Life Sciences Fund VI (GP), L.P., ("SV Fund VI GP") is the general partner of SV Life LP. The general partner of SV Fund VI GP is SVLSF VI, LLC. The members of the investment committee of SVLSF VI, LLC are Kate Bingham, Thomas Flynn, James Garvey, Eugene D. Hill, III, Paul LaViolette, and Michael Ross. Each of SV Fund VI GP, SVLSF VI, LLC and the SVLSF VI, LLC investment committee disclaims beneficial ownership of the shares owned directly by SV Life LP, except to the extent of any pecuniary interest therein.
- [F3]Represents the total number of shares of Common Stock received by SV Life Sciences Fund VI Strategic Partners, L.P. ("SV Life SP LP") upon the conversion of the Issuer's Series A Preferred Stock in connection with the closing of the Issuer's initial public offering.
- [F4]The shares are held directly by SV Life SP LP. SV Health Investors, LLC is the Manager of SV Life SP LP. SV Fund VI GP is the general partner of SV Life SP LP. The general partner of SV Fund VI GP is SVLSF VI, LLC. The members of the investment committee of SVLSF VI, LLC are Kate Bingham, Thomas Flynn, James Garvey, Eugene D. Hill, III, Paul LaViolette, and Michael Ross. Each of SV Fund VI GP, SVLSF VI, LLC and the SVLSF VI, LLC investment committee disclaims beneficial ownership of the shares owned directly by SV Life SP LP, except to the extent of any pecuniary interest therein.
- [F5]Represents the total number of shares of Common Stock received by SV Life LP upon the conversion of the Issuer's Series B Preferred Stock in connection with the closing of the Issuer's initial public offering.
- [F6]Represents the total number of shares of Common Stock received by SV Life SP LP upon the conversion of the Issuer's Series B Preferred Stock in connection with the closing of the Issuer's initial public offering.
- [F7]All series of Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 4.132-for-1 basis on June 25, 2018 and had no expiration date.
Documents
Issuer
AVROBIO, Inc.
CIK 0001681087
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001717728
Filing Metadata
- Form type
- 4
- Filed
- Jun 24, 8:00 PM ET
- Accepted
- Jun 25, 6:16 PM ET
- Size
- 27.6 KB